StockData
International Stem Cell CORP logo

International Stem Cell CORP (ISCO) stock

ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
$0.28+0.00 (+0.89%)

Close on Oct 19, 2026Market cap $2.27MP/E –Yield –

International Stem Cell price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

International Stem Cell's price to sales ratio was 0.2× on Oct 19, 2026, against 0.1× a year earlier. Over the last 5 years it ranged from 0.0× to 0.7×, with a median of 0.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.2×+0.1
2025Dec 31, 20250.1×+0.0
2024Dec 31, 20240.1×+0.0
2023Dec 29, 20230.1×−0.1
2022Dec 30, 20220.2×−0.4
2021Dec 31, 20210.6×+0.3
2020Dec 31, 20200.3×−0.2
2019Dec 31, 20190.5×−0.4
2018Dec 31, 20180.9×+0.0
2017Dec 29, 20170.9×+0.4
2016Dec 30, 20160.5×−0.5
2015Dec 31, 20151.0×−1.3
2014Dec 31, 20142.3×−2.7
2013Dec 31, 20135.0×+1.3
2012Dec 31, 20123.7×−4.3
2011Dec 30, 20118.0×–

More International Stem Cell figures

See a number that looks wrong?